BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38675425)

  • 1. Polarization of HIV-1- and CMV-Specific IL-17-Producing T Cells among People with HIV under Antiretroviral Therapy with Cannabis and/or Cocaine Usage.
    Castro FOF; Guilarde AO; Souza LCS; Guimarães RF; Pereira AJCS; Romão PRT; Pfrimer IAH; Fonseca SG
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine.
    Castro FOF; Silva JM; Dorneles GP; Barros JBS; Ribeiro CB; Noronha I; Barbosa GR; Souza LCS; Guilarde AO; Pereira AJCS; Guimarães RF; Oliveira TF; Oliveira SEF; Peres A; Romão PRT; Pfrimer IAH; Fonseca SGD
    AIDS; 2019 Oct; 33(12):1831-1842. PubMed ID: 31490211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal association of cytokine-producing CMV-specific T cells with frailty in HIV-infected and -uninfected men who have sex with men.
    Zhang W; Li H; Bream JH; Nilles TL; Leng SX; Margolick JB
    Immun Ageing; 2022 Mar; 19(1):13. PubMed ID: 35255947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus.
    Stone SF; Price P; Khan N; Moss PA; French MA
    AIDS; 2005 Mar; 19(6):555-62. PubMed ID: 15802973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.
    Boaz MJ; Waters A; Murad S; Easterbrook PJ; Vyakarnam A
    J Immunol; 2002 Dec; 169(11):6376-85. PubMed ID: 12444145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.
    Alatrakchi N; Damond F; Matheron S; Beretta-Tempelhoff S; Campa P; Carcelain G; Brun-Vezinet F; Autran B;
    AIDS; 2006 Jan; 20(1):29-34. PubMed ID: 16327316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
    Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
    Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.
    Chiu CY; Schou MD; McMahon JH; Deeks SG; Fromentin R; Chomont N; Wykes MN; Rasmussen TA; Lewin SR
    Front Immunol; 2023; 14():1123342. PubMed ID: 37056754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of CD4+ and CD8+ T-cell responses to cytomegalovirus in HIV-infected and HIV-uninfected men who have sex with men.
    Li H; Margolick JB; Bream JH; Nilles TL; Langan S; Bui HT; Sylwester AW; Picker LJ; Leng SX
    J Infect Dis; 2014 Aug; 210(3):400-4. PubMed ID: 24532602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.
    Nakiboneka R; Mugaba S; Auma BO; Kintu C; Lindan C; Nanteza MB; Kaleebu P; Serwanga J
    Vaccine; 2019 Jan; 37(1):113-122. PubMed ID: 30459072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
    Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
    J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.
    Egli A; Binet I; Binggeli S; Jäger C; Dumoulin A; Schaub S; Steiger J; Sester U; Sester M; Hirsch HH
    J Transl Med; 2008 Jun; 6():29. PubMed ID: 18541023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Infection Facilitates the Costimulation of CD57+CD28- CD8 T Cells in HIV Infection and Atherosclerosis via the CD2-LFA-3 Axis.
    Winchester NE; Panigrahi S; Haria A; Chakraborty A; Su X; Chen B; Morris SR; Clagett BM; Juchnowski SM; Yadavalli R; Villinger F; Paiardini M; Harth K; Kashyap VS; Calabrese LH; Margolis L; Sieg SF; Shive CL; Gianella S; Funderburg NT; Zidar DA; Lederman MM; Freeman ML
    J Immunol; 2024 Jan; 212(2):245-257. PubMed ID: 38047900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
    Schnittman SR; Lu MT; Mayrhofer T; Burdo TH; Fitch KV; McCallum S; Fulda ES; Zanni MV; Foldyna B; Malvestutto C; Fichtenbaum CJ; Aberg JA; Bloomfield GS; Overton ET; Currier J; Tebas P; Sha BE; Ribaudo HJ; Flynn JM; Douglas PS; Erlandson KM; Grinspoon SK
    Clin Infect Dis; 2023 Feb; 76(3):e613-e621. PubMed ID: 35975297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.